Monday, October 31, 2011

Phase III Trial of Regorafenib in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival...

›
Bayer HealthCare Pharmaceuticals, announced the results from its Phase III trial evaluating its investigational compound regorafenib (see ...

Researcher's compound disables bacteria instead of killing them

›
A microbiologist at the University of Wisconsin-Milwaukee (UWM) has discovered a different approach: Instead of killing the bacteria, wh...
Saturday, October 29, 2011

WPI Research Shows How Cranberry Juice Fights Bacteria at the Molecular Level

›
The study tested proanthocyanidins or PACs , a group of flavonoids found in cranberries . Because they were thought to be the ingredient t...
Saturday, October 22, 2011

New dual drug combinations in development for various cancers

›
New dual drug combinations in development for various cancers : A rarely used—and as yet largely unproven—approach to drug development has ...
Friday, October 21, 2011

New data on novel gene-silencing oligonucleotide technology...

›
Idera announced new data on its novel gene-silencing oligonucleotide (GSO) technology at the Cell Symposium on Regulatory RNAs in Chicag...
Wednesday, October 19, 2011

Yawning May Help the Brain Chill Out

›
Yawning May Help the Brain Chill Out : Yawning may be a natural way of regulating brain temperature, a new study suggests.U.S. researchers...
Tuesday, October 18, 2011

HSV1 drugs could slow progression of Alzheimer's disease

›
HSV1 drugs could slow progression of Alzheimer's disease : Antiviral drugs used to target the herpes virus could be effective at slowing...
Saturday, October 15, 2011

New Alzheimer's Drug Shows Early Promise

›
An experimental Alzheimer's disease drug, gantenerumab , may help lower levels of amyloid plaque in the brains of people with the di...
Friday, October 14, 2011

Ginger Supplements Might Ease Inflammation Linked to Colon Cancer..

›
A small, preliminary study finds that ginger root supplements seem to reduce inflammation in the intestines  a potential sign that the pi...
Tuesday, October 11, 2011

Teriflunomide drug reduces relapse rate of people with MS

›
 In continuation of my update on  Teriflunomide A new oral drug has been shown in a large international clinical trial to significantly re...
Monday, October 10, 2011

First combination drug to treat type 2 diabetes and high cholesterol receives FDA approval

›
In continuation of my update on Simvastin The U.S. Food and Drug Administration recently approved Juvisync ( sitagliptin and simvasta...
Thursday, October 6, 2011

Blueberry powder may control triple negative breast cancer

›
In continuation of my update on blue berry's usefulness .... Blueberry powder may control triple negative breast cancer : In several stu...
Wednesday, October 5, 2011

Health Canada approves Trajenta (linagliptin) for type 2 diabetes

›
Linagliptin (below structure, BI-1356 , trade name Tradjenta ) is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment ...
Tuesday, October 4, 2011

Novel drug shows promise for MLL leukemia

›
Novel drug shows promise for MLL leukemia : According to British scientists a potential new drug from GlaxoSmithKline could treat mixed-line...
Thursday, September 29, 2011

Drug Shows Promise Against Deadly Lung Disease

›
  An experimental drug may offer a thin ray of hope to people suffering from the rapidly fatal lung disease known as idiopathic pulmonary...
3 comments: